Kreos Capital Revenue and Competitors

London, UK

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Kreos Capital's estimated annual revenue is currently $1.4M per year.(i)
  • Kreos Capital's estimated revenue per employee is $126,000

Employee Data

  • Kreos Capital has 11 Employees.(i)
  • Kreos Capital grew their employee count by -80% last year.

Kreos Capital's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
VP - Investment TeamReveal Email/Phone
3
Venture Debt AnalystReveal Email/Phone
4
Growth Debt InvestorReveal Email/Phone
5
PrincipalReveal Email/Phone
6
AssociateReveal Email/Phone
7
Investment AnalystReveal Email/Phone
8
AssociateReveal Email/Phone
9
Office AdministratorReveal Email/Phone
10
General PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$55.7M241-24%N/AN/A
#2
$12.5M66-3%N/AN/A
#3
$3.4M230%N/AN/A
#4
$16.2M7728%N/AN/A
#5
$48M2082%N/AN/A
#6
$85.1M32419%N/AN/A
#7
$88.2M33640%N/AN/A
#8
$411M139817%N/AN/A
#9
$105.3M40155%N/AN/A
#10
$105.9M3975%$878.2MN/A
Add Company

What Is Kreos Capital?

Kreos Capital is Europe's largest and leading provider of growth debt to high-growth companies with revenues up to €200 million. Since 1998, as the pioneer growth debt provider across the UK, Western Europe, Scandinavia and Israel, Kreos has completed over 500 transactions and committed over €2 billion in 14 different countries. Kreos has a proven track record of adding value to portfolio companies and helping them to grow with additional capital and flexibility throughout their business cycle whilst working closely with both the portfolio company management team and their equity sponsors. The Kreos global team has extensive debt financing, management and equity investing experience, covering the pan-European market from its locations in London, Tel Aviv and Stockholm.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.4M

Revenue (est)

-80%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kreos Capital News

2022-04-17 - VectivBio Appoints Patrick Malloy as Senior Vice President ...

... regarding the use of funds from the debt facility with Kreos Capital and its partnership agreement with Asahi Kasei Pharma Corporation,...

2022-04-06 - PolyPid Secures $15 Million Non-Dilutive Secured Term Loan ...

Secured Loan facility with Kreos Capital Extends Company's Cash Runway into the Second Quarter of 2023. April 06, 2022 07:00 ET | Source: PolyPid Ltd.

2022-03-30 - VectivBio Announces Japan License Deal and Loan Facility ...

D., President of Asahi Kasei Pharma. VectivBio also entered into a loan facility with Kreos Capital, a leading global growth lender to life...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M11-39%$11.5M
#2
$1.7M1110%N/A
#3
$1.4M11-8%N/A
#4
$1.4M1122%N/A
#5
$1.2M11-35%N/A